Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

488
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
488
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

27
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

455
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
455
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

208
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
208
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

142
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
142
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

19
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic complications of citrate anticoagulation in continuous renal replacement therapy (crrt): a delphi consensus on indications, monitoring and management.

Critical care (London, England)·2026
Same author

Under-Investigation and Delays Experienced by Females Presenting with Chest Pain to Emergency Departments: A Study of Five Linked Canadian Hospitals.

The Journal of emergency medicine·2026
Same author

Derivation and Validation of Risk Prediction Models for Cardiovascular and Kidney Outcomes of Non-ST-Segment-Elevation Acute Coronary Syndrome in Patients With Chronic Kidney Disease.

Journal of the American Heart Association·2026
Same author

Characterizing heterogeneity in health-related quality of life trajectories in coronary artery disease: a longitudinal latent Markov analysis.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

Sex Differences in Self-Rated Health and Cardiovascular Disease Events.

JAMA network open·2026
Same author

Prophylactic anticoagulation following anterior ST-elevation myocardial infarction for prevention of left ventricular thrombus: a narrative review.

Journal of thrombosis and thrombolysis·2026
Same journal

Patients' Perspectives on Personalized Glycemic Targets for Coronary Artery Disease Prevention Based on the Haptoglobin Phenotype: A Qualitative Study.

CJC open·2026
Same journal

Initial Cardiovascular Disease Risk Assessment in Nonclinical Settings: Framingham-Simplified Model Predictive Performance in a Canadian Cohort.

CJC open·2026
Same journal

Cognition in Chronic Heart Failure: Advancing Knowledge for Better Prevention Through Remote Assessment.

CJC open·2026
Same journal

The Path Less Traveled: Embracing the Arts in Scientific Communications.

CJC open·2026
Same journal

Implementation of Integrated Behavioural Health in Outpatient Cardiology Care for Patients with Injection Drug Use-Associated Infective Endocarditis.

CJC open·2026
Same journal

Current Practice Patterns and Barriers to Intravascular Imaging-Guided Percutaneous Interventions: Insights from a Canadian Nationwide Survey.

CJC open·2026
See all related articles

Related Experiment Video

Updated: Aug 25, 2025

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

4.9K

Cardiorenal Interactions: A Review.

Sanam Verma1,2, Michelle M Graham1, Ashani Lecamwasam3,4,5

  • 1Division of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.

CJC Open
|October 18, 2022
PubMed
Summary
This summary is machine-generated.

Cardiorenal syndromes involve complex interactions between heart and kidney function. This review covers acute kidney injury, renal dysfunction complications, and renal replacement therapy for cardiologists and intensivists.

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.8K
Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
10:25

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Published on: August 30, 2011

18.2K

Related Experiment Videos

Last Updated: Aug 25, 2025

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

4.9K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.8K
Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
10:25

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Published on: August 30, 2011

18.2K

Area of Science:

  • Cardiology
  • Nephrology
  • Critical Care Medicine

Background:

  • Cardiac and renal functions are intricately linked, with disorders in one organ system impacting the other.
  • Cardiorenal syndromes encompass acute and chronic conditions arising from complex pathophysiology.
  • These syndromes result from hemodynamic changes, systemic congestion, and metabolic abnormalities.

Purpose of the Study:

  • To provide a comprehensive review of cardiorenal syndromes for cardiologists and intensivists.
  • To discuss the management of patients with intertwined cardiac and renal dysfunction.
  • To cover key aspects including acute kidney injury and renal replacement therapy.

Main Methods:

  • Literature review focusing on cardiorenal interactions.
  • Synthesis of current understanding of cardiorenal syndrome pathophysiology.
  • Discussion of clinical management strategies for affected patients.

Main Results:

  • Cardiorenal syndromes are characterized by bidirectional influence between cardiac and renal systems.
  • Acute kidney injury is a common complication in critically ill cardiac patients.
  • Effective management requires addressing hemodynamic, congestion, and metabolic factors.

Conclusions:

  • Understanding cardiorenal interactions is crucial for optimal patient care.
  • Integrated management strategies are needed for cardiorenal syndromes.
  • This review aims to enhance clinical decision-making in complex cardiorenal cases.